SRPK1 is a poor prognostic indicator and a novel potential therapeutic target for human colorectal cancer
Nan Yi,1,2,* Mingbing Xiao,1,2,* Feng Jiang,2 Zhaoxiu Liu,2 Wenkai Ni,2 Cuihua Lu,2 Runzhou Ni,2 Weichang Chen1 1Department of Gastroenterology, The First Affiliated Hospital of Soochow University, Suzhou, Jiangsu 215006, People’s Republic of China; 2Department of Gastroenterology, Affili...
Main Authors: | Yi N, Xiao M, Jiang F, Liu Z, Ni W, Lu C, Ni R, Chen W |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2018-09-01
|
Series: | OncoTargets and Therapy |
Subjects: | |
Online Access: | https://www.dovepress.com/srpk1-is-a-poor-prognostic-indicator-and-a-novel-potential-therapeutic-peer-reviewed-article-OTT |
Similar Items
-
MiR-216b suppresses colorectal cancer proliferation, migration, and invasion by targeting SRPK1
by: Yao YF, et al.
Published: (2018-03-01) -
Serine/arginine protein kinase (SRPK) inhibition as a potential therapeutic strategy against leukemia cells
by: Siqueira, Raoni Pais
Published: (2018) -
Resistance to Platinum-Containing Chemotherapy in Testicular Germ Cell Tumors Is Associated with Downregulation of the Protein Kinase SRPK1
by: Paul W. Schenk, et al.
Published: (2004-07-01) -
SRPK1/AKT axis promotes oxaliplatin-induced anti-apoptosis via NF-κB activation in colon cancer
by: Jing-Qiang Huang, et al.
Published: (2021-06-01) -
SRPK2 Phosphorylation by the AGC Kinases, and mTORC1 Regulation of Alternative Splicing
by: Dempsey, Jamie Michelle
Published: (2012)